Markets:

Overview

News

Currencies

International

Treasuries

Integra LifeSciences Holdings Corporation - Common Stock (NQ:IART)

14.00 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, May 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Integra LifeSciences Holdings Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

3 Reasons IART is Risky and 1 Stock to Buy Instead

March 14, 2025

While the broader market has struggled with the S&P 500 down 1.3% since September 2024, Integra LifeSciences has surged ahead as its stock price has climbed by 31.6% to $22.79 per share. This...

Via StockStory

Topics Stocks

3 Small-Cap Stocks in the Doghouse

March 07, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

Teleflex Earnings: What To Look For From TFX

February 26, 2025

Medical technology company Teleflex (NYSE:TFX) will be reporting earnings tomorrow before market open. Here’s what to look for.

Via StockStory

What To Expect From LeMaitre’s (LMAT) Q4 Earnings

February 26, 2025

Medical device company LeMaitre Vascular (NASDAQ:LMAT) will be announcing earnings results tomorrow after the bell. Here’s what to expect.

Via StockStory

Earnings Scheduled For February 25, 2025 ↗

February 25, 2025

Via Benzinga

Unveiling 10 Analyst Insights On Integra Lifesciences ↗

October 01, 2024

Via Benzinga

Expert Outlook: Integra Lifesciences Through The Eyes Of 8 Analysts ↗

August 22, 2024

Via Benzinga

Integra LifeSciences Analysts Cut Their Forecasts After Q2 Results ↗

July 30, 2024

Via Benzinga

INTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Integra LifeSciences Holdings Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

February 25, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Why Is Integra LifeSciences (IART) Stock Rocketing Higher Today

February 25, 2025

Shares of medical device company Integra LifeSciences (NASDAQ:IART) jumped 13.6% in the afternoon session after the company reported strong fourth quarter 2024 results that beat analysts' EPS and...

Via StockStory

Integra LifeSciences (NASDAQ:IART) Misses Q4 Revenue Estimates

February 25, 2025

Medical device company Integra LifeSciences (NASDAQ:IART) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 11.5% year on year to $442.6 million. Next quarter’s revenue guidance of...

Via StockStory

NASDAQ:IART is an undervalued gem with solid fundamentals. ↗

July 25, 2024

INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) is an undervalued gem with solid fundamentals.

Via Chartmill

8 Analysts Have This To Say About Integra Lifesciences ↗

July 15, 2024

Via Benzinga

Integra LifeSciences (IART) Reports Earnings Tomorrow: What To Expect

February 24, 2025

Medical device company Integra LifeSciences (NASDAQ:IART) will be announcing earnings results tomorrow before market hours. Here’s what to look for.

Via StockStory

Grabar Law Office is Investigating Claims on Behalf of Long-Term Shareholders of Paragon 28, Inc. (NYSE: FNA); Integra Lifesciences Holdings Corp. (NASDAQ: IART); Telephone and Data Systems, Inc. (NYSE: TDS); Methode Electronics, Inc. (NYSE: MEI); and

February 10, 2025

From Grabar Law Office

Via GlobeNewswire

Grabar Law Office is Investigating Claims on Behalf of Long-Term Shareholders of Globe Life Inc. (NYSE: GL); Paragon 28, Inc. (NYSE: FNA); Integra Lifesciences Holdings Corp. (NASDAQ: IART); Telephone and Data Systems, Inc. (NYSE: TDS); and Methode

February 06, 2025

From Grabar Law Office

Via GlobeNewswire

Notice To Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf

February 04, 2025

From Grabar Law Office

Via GlobeNewswire

Meet the Only 3 S&P 500 Stocks That Are Beating Nvidia This Year ↗

December 05, 2024

Via The Motley Fool

Topics Stocks

Why Is Integra LifeSciences Stock Soaring On Monday? ↗

November 04, 2024

Integra LifeSciences' Q3 results show adjusted EPS of $0.41 and revenue at $380.83 million. Codman segment grows 1%, while Tissue Tech sees a 3.6% decline.

Via Benzinga

Integra LifeSciences Posts Upbeat Results, Joins Air Transport Services, Freshpet, Yum China And Other Big Stocks Moving Higher On Monday ↗

November 04, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 04, 2024

Via Benzinga

Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term IART Shareholders to Contact the Firm

September 19, 2024

From KASKELA LAW LLC

Via Business Wire

Wall Street's Top 10 Stock Calls This Week - Saturday, Aug. 3 ↗

August 03, 2024

What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of July 29 through Aug. 2.

Via Talk Markets

Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 29, 2024

Via Benzinga

Why Integra Lifesciences Stock Is Sinking Today ↗

July 29, 2024

Q2 revenue and earnings beats didn't make up for the company's full-year guidance cut.

Via The Motley Fool

Topics Earnings

IART Stock Earnings: Integra Lifesciences Beats EPS, Beats Revenue for Q2 2024 ↗

July 29, 2024

IART stock results show that Integra Lifesciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

July 29, 2024

Via Benzinga

The 3 Best Brain-Computer Interface Stocks to Buy Now ↗

July 27, 2024

With the number of U.S. citizens aged 65 and above growing to 55.8 million, we could see brain-computer interface stocks accelerate.

Via InvestorPlace

INTEGRA LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Integra LifeSciences Holdings Corporation - IART

July 19, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

For those who appreciate value investing, NASDAQ:IART is a compelling option with its solid fundamentals. ↗

July 03, 2024

INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART), an undervalued stock with good fundamentals.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.